update on phase iib study of bomedemstat in essential thrombocythemia
Published 2 years ago • 744 plays • Length 2:24Download video MP4
Download video MP3
Similar videos
-
1:43
updates from a phase ii study of bomedemstat for the treatment of essential thrombocythemia
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
3:05
updates on the phase i study of ft-4202 for scd
-
1:52
results of phase i study of mcl-1 inhibition with azd5991 in r/r hematologic malignancies
-
7:42
phase ii trial of bomedemstat for advanced myelofibrosis
-
2:58
long-term follow-up: phase ii study of apr-246 aza in tp53-mutated mds & aml
-
12:49
3mensio ct pre-case planning: valve-in-valve tavr in homograft
-
1:58:22
ivt lecture and demo
-
7:26
clinical decision making processes typical to health professionals
-
1:19
telomerase inhibition as a novel targeted therapy for myelofibrosis
-
1:17
phase ii study of tosedostat in mds
-
1:34
are thrombotic risk and progression in et predictable?
-
2:03
preliminary results of a phase ii study of fedratinib in patients with mds/mpn and cnl
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
1:28
phase i study of pevonedistat and ibrutinib in r/r b-nhl
-
2:41
bomedemstat combined with ruxolitinib for the treatment of mf: early results of a phase ii trial
-
4:22
accelerated-phase mpns: pathophysiology, treatment approaches and ongoing clinical trials
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
1:23
insights into the management and treatment of accelerated/blast-phase mpns
-
2:58
results of a phase ib study of ibrutinib obinutuzumab in r/r cll
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo